| __timestamp | BioCryst Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 2819557000 |
| Thursday, January 1, 2015 | 48257000 | 4103728000 |
| Friday, January 1, 2016 | 26353000 | 4860427000 |
| Sunday, January 1, 2017 | 25186000 | 5872227000 |
| Monday, January 1, 2018 | 20653000 | 6710800000 |
| Tuesday, January 1, 2019 | 48835000 | 7863400000 |
| Wednesday, January 1, 2020 | 17812000 | 8497100000 |
| Friday, January 1, 2021 | 157170000 | 16071700000 |
| Saturday, January 1, 2022 | 270827000 | 12172900000 |
| Sunday, January 1, 2023 | 331412000 | 13117200000 |
| Monday, January 1, 2024 | 14202000000 |
In pursuit of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed BioCryst Pharmaceuticals, Inc. in terms of annual revenue. From 2014 to 2023, Regeneron's revenue surged by over 360%, peaking at approximately $13.1 billion in 2023. In contrast, BioCryst's revenue, while growing, reached a more modest $331 million in the same year, marking a significant increase from its 2014 revenue of $13.6 million.
Regeneron's impressive growth can be attributed to its robust pipeline and successful product launches, while BioCryst's steady rise reflects its strategic focus on niche markets. This comparison highlights the diverse strategies within the biotech sector and underscores the importance of innovation and market positioning in driving financial success.
Revenue Insights: AstraZeneca PLC and Regeneron Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: Pfizer Inc. vs Regeneron Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Zoetis Inc. vs BioCryst Pharmaceuticals, Inc.
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Alnylam Pharmaceuticals, Inc.?
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Genmab A/S
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Amneal Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Insights: PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. Performance Compared
Merus N.V. vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: Ligand Pharmaceuticals Incorporated vs BioCryst Pharmaceuticals, Inc.